miR-1224 通过靶向抗凋亡基因 Nfib 抑制急性肝衰竭中的细胞增殖
该研究在多种急性肝病小鼠模型及急性肝衰竭(ALF)患者中检测 miR-1224,发现缺血再灌注后肝细胞 miR-1224 上调,伴增殖受损和凋亡增加,其功能通过抑制抗凋亡基因 Nfib 介导;ALF 患者肝组织和血清 miR-1224 亦上调,提示预后不良且预后价值优于其他已知血清标志物。
要点
- 小鼠缺血再灌注后肝细胞 miR-1224 上调,伴增殖受损和凋亡增加。
- miR-1224 通过抑制抗凋亡基因 Nfib 发挥上述作用。
- ALF 患者肝组织和血清 miR-1224 上调,提示预后不良,预后价值优于其他已知血清标志物。
核心结论
- miR-1224 是肝细胞 ALF 后增殖的既往未识别调控因子,也是具有 ALF 预后价值的新型特异性肝损伤生物标志物。
- 作者认为 miR-1224 可能成为 ALF 新型治疗和诊断策略的靶点,并需在前瞻性试验中进一步验证其生物标志物价值。
研究设计与样本
- 研究检测了多种急性肝病小鼠模型肝脏及 ALF 患者中的 miR-1224,使用定量实时 PCR。
- 研究在 AML12 细胞和原代肝细胞中经 H2O2 刺激后观察 miR-1224 的调控。
- 细胞增殖和细胞死亡分别通过 5-溴-2'-脱氧尿苷和末端脱氧核苷酸转移酶缺口末端标记染色分析。
主要发现
- 体内和体外缺血再灌注后肝细胞 miR-1224 上调,伴随增殖受损和凋亡升高。
- miR-1224 的功能通过抑制肝细胞中的抗凋亡基因 Nfib 介导。
- ALF 患者肝脏和血清中 miR-1224 亦上调,提示预后不良,且在该临床情形下与其他已知血清标志物相比具有优异的预后价值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论提出 miR-1224 需在前瞻性试验中进一步验证其生物标志物价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Patient outcome in acute liver failure (ALF) is crucially determined by the appropriate balance between cell death and compensatory cell proliferation. MicroRNAs (miRNAs) - small non-coding RNAs that function as guide molecules in RNA silencing - have evolved as crucial mediators of nearly all developmental and pathological processes, including the physiology and pathology of the liver. We investigated the role of miR-1224 during ALF. METHODS: We measured miR-1224 in livers of mice in various acute liver disease murine models and in, patients with ALF, using quantitative real-time PCR. We studied the regulation of miR-1224 in AML12 cells and primary hepatocytes upon H2O2 stimulation. Cell proliferation and cell death were analysed by 5-bromo-2'-deoxyuridine and terminal deoxynucleotide transferase nick end labelling stainings, respectively. RESULTS: We found that miR-1224 was up-regulated in hepatocytes upon ischaemia-reperfusion in vivo and in vitro. This was accompanied by impaired proliferation and elevated apoptosis. This function of miR-1224 was mediated by repressing the anti-apoptotic gene Nfib in hepatocytes. Strikingly, miR-1224 was also up-regulated in human livers and the serum of patients with ALF and indicated an unfavourable prognosis with an excellent prognostic value compared to other known serum markers in this clinical setting. CONCLUSIONS: miR-1224 is a previously unrecognised regulator of proliferation after ALF in hepatocytes and represents a novel and specific biomarker of liver injury with prognostic value in ALF. Thus, miR-1224 may represent a target for novel therapeutic and diagnostic strategies in the context of ALF and warrants further testing as a biomarker in prospective trials. Lay summary: In acute liver failure, miR-1224 expression is modulated by oxidative stress. This leads to a decrease in hepatocyte cell proliferation and increase in apoptosis. Increased serum levels of miR-1224 could be a useful diagnostic marker in patients with acute liver failure.
引用
- Roy S, Bantel H, Wandrer F, et al. miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib. J Hepatol. 2017. PMID: 28645739. doi:10.1016/j.jhep.2017.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。